Hyperbaric Oxygen effect on inflammation by a heat injury model in healthy male volunteers

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-002290-36-DK

Enrollment

Registered

2011-07-27

Start date

2011-08-04

Completion date

Unknown

Last updated

2021-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

experimental Inflammation MedDRA version: 14.1 Level: LLT Classification code 10021961 Term: Inflammation NOS System Organ Class: 10018065 - General disorders and administration site conditions

Interventions

Trade Name: Medicinsk Luft "AGA" Product Name: Medicinsk Luft "AGA" Pharmaceutical Form: Inhalation gas

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Healthy male volunteers Are the trial subjects under 18? no Number of subjects for this age range: 0 F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 18 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range 0

Exclusion criteria

Exclusion criteria: Lack of ability to equalize pressure in the inner ear

Design outcomes

Primary

Measure	Time frame
Main Objective: To evaluate the effect of hyperbaric oxygen on experimental inflammation;Secondary Objective: Pain reduction;Primary end point(s): Reduction in inflammation and hyperalgesia	—

Countries

Denmark

Contacts

Public ContactMultidisciplinary Pain Center 7612

Multidisciplinary Pain Center 7612, Rigspitalet

rotboell@rh.dk004534457612

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026